XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CONSOLIDATED STATEMENTS OF CASH FLOWS    
Net income $ 27,866 $ 17,441
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Gain on sale of investment securities (362) (1,345)
Depreciation and amortization, net (4,677) (992)
Net amortization of investment premiums and discounts and change in fair value of equity securities 991 238
Provision for loan losses 1,292 7,139
Amortization of issuance costs on subordinated debt 88 83
Share-based compensation 791 300
Net change in fair value of derivative instruments 3,431 (6,346)
Net change in fair value of loans held for sale 3,164 (4,424)
Net change in fair value of loans held for investment 24 (174)
Gain on sale of OREO   (6)
Amortization and net impairment of servicing rights 707 350
Capitalization of servicing rights, net (7,021) (2,992)
SBA loan income (5,423) (1,821)
Proceeds from sale of loans 2,034,464 1,356,637
Loans originated for sale (1,864,132) (1,498,614)
Mortgage banking income (62,293) (45,395)
Decrease (increase) in accrued interest receivable 402 (1,518)
(Increase) decrease in other assets (2,648) 8,503
Earnings from investment in life insurance (224) (210)
(Increase) decrease income in deferred income tax (817) 1,274
(Decrease) increase in accrued interest payable (490) 1,170
Increase in other liabilities 1,299 9,054
Net cash provided by (used in) operating activities 126,432 (161,648)
Activity in available-for-sale securities:    
Maturities, repayments and calls 6,173 6,319
Sales 20,855 44,592
Purchases (52,468) (92,476)
Activity in held-to-maturity securities:    
Maturities, repayments and calls   2,140
Proceeds from sale of OREO   126
Decrease in restricted stock 3,699 422
Net increase in loans (82,711) (339,459)
Purchases of premises and equipment (1,496) (651)
Purchase of bank owned life insurance (10,000)  
Net cash used in investing activities (115,948) (378,987)
Cash flows from financing activities:    
Net increase in deposits 197,712 357,856
(Decrease) increase in short-term borrowings (3,187) (31,928)
Decrease in short-term borrowings with original maturity > 90 days (81,397) 12,902
(Repayment) proceeds from long-term debt, net (87,141) 247,008
Repayment of acquisition note payable   (413)
Issuance costs on subordinated debt   (231)
Net purchase of treasury stock (2,197) (5,703)
Dividends paid (8,468) (763)
Purchase of common shares for ESOP   (2,000)
Share based awards and exercises 571 405
Net cash provided by financing activities 15,893 577,133
Net change in cash and cash equivalents 26,377 36,498
Cash and cash equivalents at beginning of period 36,744 39,371
Cash and cash equivalents at end of period 63,121 75,869
Supplemental disclosure of cash flow information:    
Interest 6,976 9,581
Income taxes 11,354 2,490
Supplemental disclosure of cash flow information:    
Transfers from loans held for sale to loans held for investment $ 7,116  
Net loans sold, not settled   $ (1,657)